市場調查報告書
商品編碼
1458093
全球生物防腐市場規模、佔有率、成長分析、依產品(設備、介質)、依應用(再生醫學、生物銀行)- 2024-2031 年產業預測Global Biopreservation Market Size, Share, Growth Analysis, By Product(Equipment, Media), By Application(Regenerative Medicine, Bio-banking) - Industry Forecast 2024-2031 |
2022年全球生物防腐市場規模為21.8億美元,預計將從2023年的28.0億美元成長到2031年的205.4億美元,在預測期內(2024-2031年)複合年成長率為28.30%。
COVID-19 大流行對生物保存市場產生了重大影響,這主要是由於製藥和生物技術公司在疫苗製造方面加大了研發力度。值得注意的是,輝瑞-BioNTech、Moderna 和 Janssen 等 mRNA 疫苗由於其獨特的運輸和儲存先決條件(從超冷到冷藏條件),需要特定的生物保存技術。因此,這場流行病將對生物保存部門產生重大影響,該部門在生殖醫學、器官移植、幹細胞庫和基因庫等各個領域都至關重要。醫療保健支出的增加、醫療設施內部樣本儲存的採用以及研發投資的增加推動了市場擴張。再生醫學中組織和細胞保存需求的激增吸引了專注於生物保存的製藥實體增加資金,X-Therma Inc. 的 1300 萬美元 A 輪融資和 Ori Biotech 的 1 億美元 B 輪融資就是例證。在技術進步、產品批准和行業內戰略聯盟的支持下,企業和製藥公司對支持生物保存公司的興趣預計將進一步推動市場成長。英國蓋伊和聖托馬斯的卵巢組織冷凍生育力保存服務等措施凸顯了該領域持續的技術進步,以及生物保存工具的成本效益,預示著市場擴張的光明前景。儘管如此,儀器成本、維護費用和保存過程中潛在的組織損傷等課題可能會對市場成長構成障礙。
Global Biopreservation Market size was valued at USD 2.18 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 20.54 billion by 2031, growing at a CAGR of 28.30% during the forecast period (2024-2031).
The COVID-19 pandemic significantly impacted the biopreservation market, primarily due to heightened research and development efforts by pharmaceutical and biotech firms in crafting vaccines. Notably, mRNA vaccines such as Pfizer-BioNTech, Moderna, and Janssen necessitated specific biopreservation techniques owing to their distinct shipping and storage prerequisites, ranging from ultra-cold to refrigerated conditions. Consequently, the pandemic's influence is poised to be substantial on the biopreservation sector, which holds vital importance in various domains like reproductive medicine, organ transplantation, stem cell banking, and gene banking. Market expansion is fueled by escalated healthcare spending, the uptake of in-house sample storage in medical facilities, and amplified investments in research and development. The surge in demand for tissue and cell preservation in regenerative medicine has attracted augmented funding for biopreservation-focused pharmaceutical entities, exemplified by X-Therma Inc.'s USD 13 million Series A funding and Ori Biotech's USD 100 million Series B funding. Entrepreneurial and pharmaceutical interest in backing biopreservation firms is expected to further propel market growth, supported by technological advancements, product approvals, and strategic alliances within the industry. Initiatives like Guy's and St Thomas' fertility preservation service for ovarian tissue cryopreservation in the UK underscore the ongoing technological strides in the field, alongside the cost-efficiency of biopreservation tools, heralding promising prospects for market expansion. Nonetheless, challenges such as instrument costs, maintenance expenses, and potential tissue damage during preservation could pose obstacles to market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopreservation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Biopreservation Market Segmental Analysis
The global biopreservation market is segmented based on product, application, and region. In terms of product, the market is segmented into equipment, media, and laboratory information management system (LIMS). Based on application, the market is segmented into regenerative medicine, bio-banking, drug discovery. Regionwise, the global biopreservation market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers of the Global Biopreservation Market
The increasing emphasis on personalized medicine and tailored treatments has heightened the need for biopreservation solutions, essential for safeguarding biological samples such as cells, tissues, and organs, serving critical roles in research, diagnosis, and therapeutic endeavors.
Restraints in the Global Biopreservation Market
Biopreservation technologies and services often come with a hefty price tag, especially when considering long-term storage and extensive biobanking endeavors. The significant expenses involved in acquiring equipment, managing maintenance, and meeting operational demands can serve as a barrier, constraining the widespread implementation of biopreservation solutions, particularly in areas with limited resources.
Market Trends of the Global Biopreservation Market
The biopreservation market experiences a notable uptick in demand primarily fueled by the growing interest in cell-based treatments like stem cell and CAR-T cell therapies. The preservation of cell viability and functionality throughout storage and transportation is pivotal, accentuating the necessity for enhanced biopreservation methods and remedies.